Next Article in Journal / Special Issue
Antioxidant Approaches to Management of Ionizing Irradiation Injury
Previous Article in Journal
Effect of Addition of Natural Antioxidants on the Shelf-Life of “Chorizo”, a Spanish Dry-Cured Sausage
Previous Article in Special Issue
Curcumin Stimulates the Antioxidant Mechanisms in Mouse Skin Exposed to Fractionated γ-Irradiation
Article Menu

Export Article

Antioxidants 2015, 4(1), 68-81; doi:10.3390/antiox4010068

Review
Modulation of Radiation Response by the Tetrahydrobiopterin Pathway
Rupak Pathak 1,, Amrita K. Cheema 2,3,, Simina M. Boca 2,4, Kimberly J. Krager 1, Martin Hauer-Jensen 1,5 and Nukhet Aykin-Burns 1,*
1
Division of Radiation Health, Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, Biomed II, Room 441A-2, 4301 West Markham #522-10, Little Rock, AR 72205, USA
2
Department of Oncology, Georgetown University Medical Center, Washington, DC 20057, USA
3
Department of Biochemistry, Molecular and Cellular Biology, Georgetown University Medical Center, Washington, DC 20057, USA
4
Innovation Center for Biomedical Informatics, Georgetown University Medical Center, Washington, DC 20057, USA
5
Surgical Service, Central Arkansas Veterans Healthcare System, Little Rock, AR 72205, USA
These authors contributed equally to this work.
*
Author to whom correspondence should be addressed; Tel.: +1-501-603-1375; Fax: +1-501-686-6057.
Academic Editor: Nikolai Gorbunov
Received: 18 November 2014 / Accepted: 13 January 2015 / Published: 22 January 2015

Abstract

: Ionizing radiation (IR) is an integral component of our lives due to highly prevalent sources such as medical, environmental, and/or accidental. Thus, understanding of the mechanisms by which radiation toxicity develops is crucial to address acute and chronic health problems that occur following IR exposure. Immediate formation of IR-induced free radicals as well as their persistent effects on metabolism through subsequent alterations in redox mediated inter- and intracellular processes are globally accepted as significant contributors to early and late effects of IR exposure. This includes but is not limited to cytotoxicity, genomic instability, fibrosis and inflammation. Damage to the critical biomolecules leading to detrimental long-term alterations in metabolic redox homeostasis following IR exposure has been the focus of various independent investigations over last several decades. The growth of the “omics” technologies during the past decade has enabled integration of “data from traditional radiobiology research”, with data from metabolomics studies. This review will focus on the role of tetrahydrobiopterin (BH4), an understudied redox-sensitive metabolite, plays in the pathogenesis of post-irradiation normal tissue injury as well as how the metabolomic readout of BH4 metabolism fits in the overall picture of disrupted oxidative metabolism following IR exposure.
Keywords:
ionizing radiation; metabolomics; oxidative stress; tetrahydrobiopterin

1. Introduction

Both targeted radiotherapy to treat malignancies and nuclear/accidental irradiation exposure are known to cause injury to normal tissues, limiting the therapeutic dose range in clinical settings or causing mass casualties [1,2,3]. Therefore, there is an imminent and unmet need to develop radiation mitigators and improve overall quality of life of individuals who are exposed to irradiation by any means. There is emerging awareness of the concept that total body radiation injury is due to multi organ dysfunction syndromes [4,5,6,7,8]. To foster feasible strategies to mitigate radiation induced multi organ tissue damage, it is imperative to identify the biological targets of Ionizing radiation (IR) and understand the interactions of these targets with each other within the entire biochemical and molecular machinery of human physiology.

A metabolomics approach offers to detect and quantitate changes in the levels of metabolites that directly reflect the overall physiological status of an individual [9]. It provides a systems wide biological snapshot of the net expression of metabolites from several known pathways in response to exogenous challenges such as IR. Cellular radiation response and damage is a result of both direct and indirect effects of radiation. Direct radiation damage is caused by specific bond breakage or modification within biomolecules including DNA, proteins and lipids. While radiolysis of water leads to the rapid generation of reactive oxygen species (ROS) resulting in oxidative stress [10,11], which is characterized by dramatic effects on cellular function; including gene expression, transcription factor activation, redox sensitive signaling pathways. All of these effects contribute to IR-induced signaling and adaptive responses, which feed into endogenous metabolism. Therefore, utilizing a metabolomics approach to study IR-induced normal tissue injury would provide invaluable information complementary to traditional radiobiology as well as genomics and proteomics studies.

Recent advances in high-resolution chromatography and mass spectrometry have enabled researchers to use this approach to discover and develop predictive biomarkers for radiation injury [12,13,14,15,16]. IR dependent metabolomics changes have already been reported in human cell lines and mouse urine, indicating multiple oxidation sensitive targets in their metabolic profiles shortly following exposure [17,18,19].

2. Cellular Redox Responses Following Radiation Exposure

The generation of ROS and reactive nitrogen species (RNS) following IR exposure, such as superoxide and hydrogen peroxide (H2O2), and peroxynitrite anion and peroxynitrous acid, respectively, cause further damage to DNA and cellular compartments. The damage leads to an imbalance in the stoichiometry of biochemical reactions and perturbation of critical pathways [20,21,22,23,24,25,26,27,28]. This deviation from cellular homeostasis then leads to a cascade of events involving additional formation of intracellular oxidants and reductants via the mitochondrial electron transport chain, stress mechanisms, and altered expression of ROS producing enzymes. Thus, it is becoming more evident that disruption in intracellular metabolic redox homeostasis will remain compromised for longer periods of time following IR [11,29,30].

While a great deal is known about the initial ROS formation shortly after IR exposures, the contribution of the effected enzymatic and/or non-enzymatic antioxidant machinery due to the formation of RNS is only beginning to be established. Although a cell is equipped with a variety of antioxidants to detoxify increased levels of ROS and RNS, they may rapidly become depleted following radiation exposure.

Tetrahydrobiopterin (BH4) is one of the critical cellular non-enzymatic redox sensitive antioxidants. It plays several critical roles in diverse bio-chemical pathways because of its cofactor function for a number of enzymes, such as aromatic amino acid hydroxylases and nitric oxide synthases (NOSs) [31]. Oxidation of BH4 to dihydrobiopterin (BH2) and other oxidized biopterin species causes endothelial NOS (eNOS) to produce higher superoxide levels instead of nitric oxide (NO), a phenomenon popularly termed as “eNOS uncoupling” resulting in increased oxidative stress [32]. The oxidation of BH4 to BH2 also further uncouples eNOS due to the ability of BH2 to compete and displace BH4 from eNOS. BH4 insufficiency-dependent eNOS uncoupling has been suggested as an etiologic factor in the progression and the subsequent development of various neurological, cardiovascular and fibrotic diseases [33]. BH4 treatment suppresses these oxidative stress-dependent adverse pathophysiological conditions [34]. Therefore, maintenance of cellular BH4 homeostasis is critical for normal physiological functioning. This critical balance of BH4 can be altered by differential intrinsic as well as extrinsic stimuli, including IR.

3. Radiation Effect on BH4 and Peroxynitrite Formation

Although literature describing the effect of IR on BH4 is limited, recent in vivo studies have shown that IR causes decreased BH4 level in tissue [35]. Berbee et al., (2010) showed that total body irradiation (TBI) of mice with 8.5 Gy of γ-ray suppressed BH4 bioavailability in lung tissue samples at 3.5 day [36]. However, the authors observed the initial decline returned to basal levels at day 7 and a compensatory increase in lung BH4 levels at later post-irradiation time points (day 14 and day 21) [36]. Similarly, a significant reduction in the BH4 level as well as BH4/BH2 ratio, which is considered as a critical determinant of eNOS uncoupling, was noticed in the lung tissue of mice 24 h following 8.5 Gy of TBI [35]. This insufficiency of BH4 availability leads to eNOS uncoupling-mediated higher superoxide generation, which in turn may react with NO to produce peroxynitrite; a powerful toxic oxidant that enhances nitrosative stress in biological system. Peroxynitrite can also oxidize BH4 to BH2 forming a vicious cycle of eNOS uncoupling [37]. The rate constant for peroxynitrite and BH4 reaction is 6–10 times greater than peroxynitrite and many cellular antioxidants making BH4 a major oxidative target [38]. Deficiency in NO or enhanced production of peroxynitrite is a critical marker of endothelial dysfunction and a major cause of pathogenesis of fibrotic diseases [39]. Berbee et al., (2010) reported that IR, in addition to BH4 deficiency, also causes increased production of peroxynitrite in mice aorta after exposure to 8.5 Gy of TBI [36], indicating a function mediated by uncoupled eNOS as a result of IR-induced BH4 unavailability. To further determine whether IR-induced aortal peroxynitrite formation is BH4-eNOS-dependent, they treated irradiated mice with BH4 or NH4 (a compound with similar antioxidant property like BH4, but with no eNOS co-factor function) and measured aortal peroxinitrite formation at different post-irradiation time points. Interestingly, they found BH4, but not NH4, was able to suppress IR-induced peroxynitrite formation, which clearly indicates BH4-dependent eNOS function is critical, not the free radical scavenging property of the compounds [36]. A recent study with a transgenic mouse model has further clarified that in vivo BH4 deficiency causes higher IR-induced aortal peroxynitrite formation in the lung tissue sample, as compared to their age-matched wild-type littermates [35]. Hanaue et al., (2007) found IR-induced salivary gland dysfunction in mice is a result of increased formation of peroxynitrite [40]. A significantly higher plasma peroxynitrite level was observed in medical staff exposed to an occupational source of IR [41]. All these data suggesting IR promotes peroxynitrite formation, thereby impairing normal physiologic functions, which might be a result of low BH4 availability after radiation exposure. In addition to IR, BH4 biosynthesis can also be modulated by amino acids, hormones, cytokines, therapeutic agents, substances derived from endothelial cells, oxidants and antioxidants, primarily through modulating the expression of the first and the rate limiting enzyme involved in de novo BH4 biosynthetic pathway, called guanosine triphosphate cyclohydrolase-1 (GTPCH1) [42,43,44,45,46,47,48].

4. Radiation Effect on GFRP and the Molecular Signaling Pathways that Modulates BH4 Biosynthesis

The activity of GTPCH1 has been shown to be inhibited by GTPCH1 Feedback Regulatory Protein (GFRP) by a protein-protein interaction in presence of the end-product in the de novo BH4 biosynthetic pathway, BH4, thereby forming a negative feedback loop [48]. The expression of GFRP can be expected to inversely modulate BH4 biosynthesis. Indeed, a number of previously published articles have revealed that pro-inflammatory stimuli- or H2O2-mediated GFRP suppression promotes BH4 bioavailability in endothelial cells [49,50]. However, the effect of IR on GFRP is not well documented in literature. Recent studies have shown GFRP expression was increased at the mRNA level in lung and liver tissue samples of wild-type mice after 8.5 Gy of TBI, indicating a GFRP-mediated inhibition of GTPCH1 activity as a possible mechanism of BH4 suppression after IR exposure [35,51]. Moreover, our group previously demonstrated vitamin E analog gamma tocotrienol (GT3) prevented the reduction of lung BH4 bioavailability on day 3.5, followed by a compensatory increase in BH4 level on day 14 and 21 after 8.5 Gy of TBI [36]. The GT3-mediated attenuation of decreased BH4 bioavailability after irradiation could be attributed to GFRP differential regulation. Our in vitro data clearly indicate that GT3 treatment significantly reduces GFRP expression at the mRNA and protein level, as well as, significantly prevented GFRP-GTPCH1 binding in endothelial cells, without modulating the expression of GTPCH1 [36]. However, it has been shown BH4 synthesis is modulated in a GFRP independent manner. Tatham et al., (2009) reported that cellular GFRP expression is not a determining factor for BH4 availability; rather GTPCH1 expression is the primary regulator [52]. Shiraishi et al., (2011) also showed that a type-III phosphodiesterase inhibitor suppressed cytokine-induced BH4 biosynthesis in endothelial cells by inhibiting GTPCH1 activity without modulating GFRP expression [53]. The mechanism by which IR regulates BH4 biosynthesis via modulating other molecular signaling pathways is not well characterized.

IR is known to activate the NF-κB pathway in different cell types depending on the radiation dose [54]. Activated NF-κB translocates into nucleus, binds to a specific site on DNA and regulates the expression of various genes, including the inducible form of NOS enzyme (iNOS), which is a major source of NO production under oxidative stress condition. Hanaue et al., (2007) has shown that IR-induced oxidative stress up-regulates iNOS-mediated NO production in salivary gland cells and is the major cause of salivary gland dysfunction [40]. Although IR is known to stimulate the activity of both iNOS and eNOS, the mechanism of enhanced activity is completely different. Radiation-induced eNOS activation is regulated by ATM and HSP-90 [55], while it has been recently shown that iNOS activation via NF-κB pathway occurs immediately following radiation exposure (within 2 h) [56]. IR promotes iNOS synthesis in a NF-κB-dependent manner inducing NO production, which may in turn interact with IR-induced superoxide to form peroxynitrite [57,58]. Peroxynitrite has the potential to oxidize BH4, suggesting a critical role of the NF-κB pathway in modulating BH4 bioavailability after IR exposure [59]. Furthermore, Huang et al., (2005) reported the NF-κB pathway, in combination with the STAT signaling pathway, plays a critical role in regulating GTPCH1 expression [60]. JAK-STAT pathway activation has been shown to be a result of IR-induced DNA damage, which indicates a possible involvement of JAK-STAT pathway in IR-induced BH4 deficiency [61].

5. Possible Mechanisms of IR-Induced BH4 Deficiency-Mediated Fibrosis Development

Various tissues are known to develop a fibrotic disorder months after the initial radiation insult, which is a consequence of delayed radiation effects. Chronic oxidative stress and inflammation are known to help drive the late effects and fibrosis, suggesting that IR-induced BH4 deficiency might play a direct and/or indirect role in tissue fibrosis (Figure 1).

The molecular mechanism of liver injury as a consequence of IR exposure, especially in the context of concomitant chemotherapy, is not well understood [62,63,64,65]. IR-induced BH4 deficiency promotes formation of peroxynitrite, which is known to play a major role in tissue fibrosis [66], consequently it could directly increase fibrotic response of this tissue following radiation. Furthermore, it has been demonstrated that liver fibrosis from late radiation effects correlated with the increase in intracellular TGFβ1 levels [67]. TGFβ1 activation and overexpression following chronic inflammation has been shown to increase significantly in the IR exposed livers. Anscher et al., also showed TGFβ1 injections in irritated livers produced a significant fibrotic reaction. Suppression of TGFβ1 activation prevents IR-induced fibrosis in mice [58]. Because peroxynitrite also augments the release of matrix metalloproteinase, a critical factor for fibrotic development via activation of TGFβ1 and NF-κB pathway, it is logical to hypothesize that decreased levels of BH4 following IR exposure might indirectly contribute to liver fibrosis following radiation as well.

Figure 1. Major pathways by which BH4 deficiency-mediated fibrosis manifests following IR. BH4, tetrahydrobiopterin; IR, Ionizing radiation
Figure 1. Major pathways by which BH4 deficiency-mediated fibrosis manifests following IR. BH4, tetrahydrobiopterin; IR, Ionizing radiation
Antioxidants 04 00068 g001 1024

In addition to liver fibrosis, TGFβ1 serum levels were recently examined to determine the extent of fibrosis in breast cancer patients following radiation. The levels correlated with the severity of fibrosis observed and may be used as a biomarker [68]. Deficient NO production is one of the critical indicators of fibrotic diseases in tissues such as heart, which may be inadequate after radiation exposure. Patients with fibrotic disorder have been shown to produce low NO [69,70]. A study utilizing an animal model has shown BH4 supplementation attenuates fibrosis development [71]. Therefore, BH4 oxidation after radiation exposure might expect to attenuate NO production via “eNOS uncoupling” and subsequently help in disease progression in various tissues [59,72,73,74].

6. Metabolomics Enhances Our View of BH4’s Role in Radiation Response

Metabolomics enables us to determine the precise changes in the metabolites endogenous levels following exposure to different doses and quality of radiation over time. We have recently used a metabolomics approach to characterize metabolic changes in an otherwise asymptomatic liver tissue following gamma radiation exposure [51]. We applied a combination of untargeted and targeted quantitative mass spectrometry to study the changes in IR-induced liver injury in mice overexpressing Gfrp, which resulted in decreased levels of BH4 as we previously discussed in this review. Our data demonstrated that when exposed to a non-lethal dose of IR, Gfrp overexpressing mice exhibited a significant accumulation of metabolites associated with oxidative stress and lipid peroxidation. Moreover, IR exposure exacerbated dysregulation of lipid metabolism and caused increased expression of genes that facilitate liver fibrosis in a time dependent manner [51].

All the markers indicative of liver damage and fibrosis were significantly higher in IR exposed Gfrp knock-in mice compared to their irradiated wild type littermates. In addition, using metabolomics we were able to detect these biomarkers at very early time points. Gfrp transgenic mice demonstrated decreased levels of glutathione and bilirubin, but increased levels of glycoholic acid, N-arachidonyl taurine, FAD and bile acids as early as 24 to 96 h. The significance of these findings is two-fold. First, our data strongly exhibited the impact of BH4 bioavailability in regulating redox homeostasis and lipid/fatty acid metabolism against IR-induced stress. Secondly, we effectively used metabolomics to show significant changes of metabolites in liver, a late responding tissue, quickly following IR exposure [51].

Others also used similar approaches to define changes in metabolites in other tissues. The response of skin tissue to low-dose radiation mimics the radiobiology of tissues exposed to high-dose radiation, suggesting that biomarkers may be available even at low-dose radiation exposures [75]. Metabolomic profiling of human skin tissue cultures exposed to low dose (< or equal to 10 cGy) ionizing radiation revealed dose and time dependent perturbations in pathways of DNA/RNA damage and repair and lipid and energy metabolism. Changes in metabolites were significantly different from controls at 48 h but not at earlier time points, reflecting a delayed radiation response [75].

Determining changes in biochemical mechanisms and oxidative/reductive metabolism following radiation and how these processes can be manipulated, holds great promise in the radiation field. Identifying novel strategies can enhance therapeutic responses to radiation and mitigate its deleterious effects as well as gather mechanistic information critical for radiation risk assessment for various tissues. Possible biomarkers from selected recent radiation studies using animal models are summarized in Table 1 [19,51,76,77,78,79,80,81].

7. Conclusions

Metabolic oxidative stress has been widely accepted as a significant contributor for the early and late effects of IR injury. There is mounting evidence showing how subtle changes in IR induced oxidative/reductive pathways could result in a snowball effect and damage organs unless they are mitigated in a timely manner. Identification of radiation induced asymptomatic tissue injury may lead to a better understanding of metabolic pathway perturbations to be used for the development of mitigators or protectors of radiation induced damage. Developments of new technologies in “omics” fields appear to be very effective in achieving this goal. Metabolomics approaches can be informative not only for developing predictive biomarkers with potential utility to screen at-risk population but also for delineating specific pathway perturbations that would augment the development of effective radio protectors as well as mitigators. Moreover, a systems biology approach which interrogates different levels of cellular expression leading to integration of transcriptomics, proteomics and metabolomics changes offers to provide novel insights and add value towards identification and characterization of biomarkers of IR stress.

Table 1. Possible biomarkers reported in selected recent metabolomics studies were either downregulated or upregulated in irradiated animals.
Table 1. Possible biomarkers reported in selected recent metabolomics studies were either downregulated or upregulated in irradiated animals.
Possible BiomarkersMethod UsedAnimal ModelsSpecimenYear Reference
Downregulated in WT miceUPLC-ESI-QTOFMS, SID-MRM-MSMiceLiver tissue2014 [51]
Bilirubin, AMD, cytidine, glycerophospholipids, 6-acetyl-d-glucose, C16 sphingomyelin
Upregulated in WT mice
Secondary bile acids, PS (22:1/0:0)
Downregulated in Gfrp mice
Glutathione, carnitines, lysoPCs
Upregulated in Gfrp transgenic mice
Glycocholic acid, N-arachidonoyl taurine, flavin adenine dinucleotide, bile acids
UpregulatedGC-TOFMSRatsSerum2012 [76]
Inositol, serine, lysine, glycine, threonine, glycerol
Downregulated
Isocitrate, gluconic acid, stearic acid
UpregulatedUPLC-ESI-QTOFMSRhesus monkeysUrine2012 [77]
N-acetyltaurine, isethionic acid, taurine, xanthine, hypoxanthine, uric acid, creatine, creatinine, tyrosol sulfate, 3-hydroxytyrosol sulfate, tyramine sulfate, N-acetylserotonin sulfate, adipic acid
Upregulated1H NMRMiceSerum2011 [78]
Lactate, amino acids, choline, lipid signals
Downregulated
Glucose signals
UpregulatedUPLC-ESI-QTOFMSRatsUrine2011 [79]
thymidine, 2′-deoxyuridine, 2′-deoxyxanthosine, N1-acetylspermidine, N-acetylglucosamine/galactosamine-6-sulfate, N-acetyltaurine, N-hexanoylglycine, taurine, isethionic acid (tentative)
UpregulatedGC-MSRatsUrine2009 [80]
Glyoxylate, threonate, thymine, uracil, p-cresol
Downregulated
Citrate, 2-oxoglutarate, adipate, pimelate, suberate, azelaate
UpregulatedUPLC-QTOFMSMiceUrine2009 [81]
thymidine, 2′-deoxyuridine, 2′-deoxyxanthosine, xanthine, xanthosine
UpregulatedUPLC–TOFMSMiceUrine2008 [19]
N-hexanoylglycine, β-thymidine, 3-hydroxy-2-methylbenzoic acid 3-O-sulfate, taurine

Acknowledgments

Authors would like to acknowledge the following funding sources: NIEHS R15 ES022781, NCI R37 CA71382, NIAID U19 AI67798, NCI P30-CA051008, NASA-NSBRI RE0370, ASTA 15-B-19 and the US Veterans Administration. Rupak Pathak and Amrita Cheema contributed equally.

Conflicts of Interest

All authors declare no conflict of interest.

References

  1. Rana, S.; Kumar, R.; Sultana, S.; Sharma, R.K. Radiation-induced biomarkers for the detection and assessment of absorbed radiation doses. J. Pharm. Bioallied Sci. 2010, 2, 189–196. [Google Scholar] [CrossRef] [PubMed]
  2. Hauer-Jensen, M.; Kumar, K.S.; Wang, J.; Berbee, M.; Fu, Q. Intestinal toxicity in radiation and combined injury: Significance, mechanisms, and countermeasures. In Global Terrorism Issues and Developments; Larche, R.A., Ed.; Nova Science Publishers: New York, NY, USA, 2007; pp. 61–100. [Google Scholar]
  3. Citrin, D.; Cotrim, A.P.; Hyodo, F.; Baum, B.J.; Krishna, M.C.; Mitchell, J.B. Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist 2010, 15, 360–371. [Google Scholar] [CrossRef] [PubMed]
  4. Hafer, N.; Cassatt, D.; Dicarlo, A.; Ramakrishnan, N.; Kaminski, J.; Norman, M.K.; Maidment, B.; Hatchett, R. NIAID/NIH radiation/nuclear medical countermeasures product research and development program. Health Phys. 2010, 98, 903–905. [Google Scholar] [CrossRef] [PubMed]
  5. Grace, M.B.; Moyer, B.R.; Prasher, J.; Cliffer, K.D.; Ramakrishnan, N.; Kaminski, J.; Coleman, C.N.; Manning, R.G.; Maidment, B.W.; Hatchett, R. Rapid radiation dose assessment for radiological public health emergencies: Roles of niaid and barda. Health Phys. 2010, 98, 172–178. [Google Scholar] [CrossRef] [PubMed]
  6. Di Carlo, A.L.; Ramakrishnan, N.; Hatchett, R.J. Radiation combined injury: Overview of niaid research. Health Phys. 2010, 98, 863–867. [Google Scholar] [CrossRef] [PubMed]
  7. Rothman, N.; Stewart, W.F.; Schulte, P.A. Incorporating biomarkers into cancer epidemiology: A matrix of biomarker and study design categories. Cancer Epidemiol. Biomark. Prev. 1995, 4, 301–311. [Google Scholar]
  8. Horan, J.R.; Gammill, W.P. The health physics aspects of the SL-1 accident. Health Phys. 1963, 9, 177–186. [Google Scholar] [CrossRef] [PubMed]
  9. Johnson, C.H.; Gonzalez, F.J. Challenges and opportunities of metabolomics. J. Cell. Physiol. 2012, 227, 2975–2981. [Google Scholar] [CrossRef] [PubMed]
  10. Cohen, S.R.; Cohen, E.P. Chronic oxidative stress after irradiation: An unproven hypothesis. Med. Hypotheses 2013, 80, 172–175. [Google Scholar] [CrossRef] [PubMed]
  11. Spitz, D.R.; Azzam, E.I.; Li, J.J.; Gius, D. Metabolic oxidation/reduction reactions and cellular responses to ionizing radiation: A unifying concept in stress response biology. Cancer Metastasis Rev. 2004, 23, 311–322. [Google Scholar] [CrossRef] [PubMed]
  12. Coy, S.L.; Cheema, A.K.; Tyburski, J.B.; Laiakis, E.C.; Collins, S.P.; Fornace, A., Jr. Radiation metabolomics and its potential in biodosimetry. Int. J. Radiat. Biol. 2011, 87, 802–823. [Google Scholar] [CrossRef] [PubMed]
  13. Patterson, A.D.; Lanz, C.; Gonzalez, F.J.; Idle, J.R. The role of mass spectrometry-based metabolomics in medical countermeasures against radiation. Mass Spectrom. Rev. 2010, 29, 503–521. [Google Scholar] [PubMed]
  14. Nicholson, J.K.; Lindon, J.C. Systems biology: Metabonomics. Nature 2008, 455, 1054–1056. [Google Scholar] [CrossRef]
  15. Blow, N. Metabolomics: Biochemistry’s new look. Nature 2008, 455, 697–700. [Google Scholar] [CrossRef] [PubMed]
  16. Zhou, B.; Xiao, J.F.; Tuli, L.; Ressom, H.W. LC-MS-based metabolomics. Mol. Biosyst. 2012, 8, 470–481. [Google Scholar] [CrossRef] [PubMed]
  17. Varghese, R.S.; Cheema, A.; Cheema, P.; Bourbeau, M.; Tuli, L.; Zhou, B.; Jung, M.; Dritschilo, A.; Ressom, H.W. Analysis of LC-MS data for characterizing the metabolic changes in response to radiation. J. Proteome Res. 2010, 9, 2786–2793. [Google Scholar] [CrossRef] [PubMed]
  18. Patterson, A.D.; Li, H.; Eichler, G.S.; Krausz, K.W.; Weinstein, J.N.; Fornace, A.J., Jr.; Gonzalez, F.J.; Idle, J.R. UPLC-ESI-TOFMS-based metabolomics and gene expression dynamics inspector self-organizing metabolomic maps as tools for understanding the cellular response to ionizing radiation. Anal. Chem. 2008, 80, 665–674. [Google Scholar] [CrossRef] [PubMed]
  19. Tyburski, J.B.; Patterson, A.D.; Krausz, K.W.; Slavik, J.; Fornace, A.J., Jr.; Gonzalez, F.J.; Idle, J.R. Radiation metabolomics. 1. Identification of minimally invasive urine biomarkers for γ-radiation exposure in mice. Radiat. Res. 2008, 170, 1–14. [Google Scholar] [CrossRef] [PubMed]
  20. Slane, B.G.; Aykin-Burns, N.; Smith, B.J.; Kalen, A.L.; Goswami, P.C.; Domann, F.E.; Spitz, D.R. Mutation of succinate dehydrogenase subunit C results in increased O2•−, oxidative stress, and genomic instability. Cancer Res. 2006, 66, 7615–7620. [Google Scholar] [CrossRef] [PubMed]
  21. Aykin-Burns, N.; Slane, B.G.; Liu, A.T.; Owens, K.M.; O’Malley, M.S.; Smith, B.J.; Domann, F.E.; Spitz, D.R. Sensitivity to low-dose/low-let ionizing radiation in mammalian cells harboring mutations in succinate dehydrogenase subunit C is governed by mitochondria-derived reactive oxygen species. Radiat. Res. 2011, 175, 150–158. [Google Scholar] [CrossRef] [PubMed]
  22. Oberley, L.W.; Lindgren, L.A.; Baker, S.A.; Stevens, R.H. Superoxide lon as the cause of the oxygen effect. Radiat. Res. 1976, 68, 320–328. [Google Scholar] [CrossRef] [PubMed]
  23. Biaglow, J.E.; Mitchell, J.B.; Held, K. The importance of peroxide and superoxide in the X-ray response. Int. J. Radiat. Oncol. Biol. Phys. 1992, 22, 665–669. [Google Scholar] [CrossRef] [PubMed]
  24. Petkau, A.; Chelack, W.S.; Pleskach, S.D. Letter: Protection of post-irradiated mice by superoxide dismutase. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 1976, 29, 297–299. [Google Scholar] [CrossRef] [PubMed]
  25. Dayal, D.; Martin, S.M.; Owens, K.M.; Aykin-Burns, N.; Zhu, Y.; Boominathan, A.; Pain, D.; Limoli, C.L.; Goswami, P.C.; Domann, F.E.; et al. Mitochondrial complex ii dysfunction can contribute significantly to genomic instability after exposure to ionizing radiation. Radiat. Res. 2009, 172, 737–745. [Google Scholar] [CrossRef] [PubMed]
  26. Lee, S.J.; Lenton, E.A.; Sexton, L.; Cooke, I.D. The effect of age on the cyclical patterns of plasma LH, FSH, oestradiol and progesterone in women with regular menstrual cycles. Hum. Reprod. 1988, 3, 851–855. [Google Scholar] [PubMed]
  27. Wallace, M.; Hashim, Y.Z.; Wingfield, M.; Culliton, M.; McAuliffe, F.; Gibney, M.J.; Brennan, L. Effects of menstrual cycle phase on metabolomic profiles in premenopausal women. Hum. Reprod. 2010, 25, 949–956. [Google Scholar] [CrossRef] [PubMed]
  28. Katz, F.H.; Romfh, P.; Smith, J.A. Diurnal variation of plasma aldosterone, cortisol and renin activity in supine man. J. Clin. Endocrinol. Metab. 1975, 40, 125–134. [Google Scholar] [CrossRef] [PubMed]
  29. Limoli, C.L.; Giedzinski, E.; Morgan, W.F.; Swarts, S.G.; Jones, G.D.; Hyun, W. Persistent oxidative stress in chromosomally unstable cells. Cancer Res. 2003, 63, 3107–3111. [Google Scholar] [PubMed]
  30. Clutton, S.M.; Townsend, K.M.; Walker, C.; Ansell, J.D.; Wright, E.G. Radiation-induced genomic instability and persisting oxidative stress in primary bone marrow cultures. Carcinogenesis 1996, 17, 1633–1639. [Google Scholar] [CrossRef] [PubMed]
  31. Thony, B.; Auerbach, G.; Blau, N. Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem. J. 2000, 347 Pt 1, 1–16. [Google Scholar] [CrossRef] [PubMed]
  32. Crabtree, M.J.; Tatham, A.L.; Hale, A.B.; Alp, N.J.; Channon, K.M. Critical role for tetrahydrobiopterin recycling by dihydrofolate reductase in regulation of endothelial nitric-oxide synthase coupling: Relative importance of the de novo biopterin synthesis versus salvage pathways. J. Biol. Chem. 2009, 284, 28128–28136. [Google Scholar] [CrossRef] [PubMed]
  33. Kietadisorn, R.; Juni, R.P.; Moens, A.L. Tackling endothelial dysfunction by modulating nos uncoupling: New insights into its pathogenesis and therapeutic possibilities. Am. J. Physiol. Endocrinol. Metab. 2012, 302, E481–E495. [Google Scholar] [CrossRef] [PubMed]
  34. Moens, A.L.; Kass, D.A. Therapeutic potential of tetrahydrobiopterin for treating vascular and cardiac disease. J. Cardiovasc. Pharmacol. 2007, 50, 238–246. [Google Scholar] [CrossRef] [PubMed]
  35. Pathak, R.; Pawar, S.A.; Fu, Q.; Gupta, P.K.; Berbee, M.; Garg, S.; Sridharan, V.; Wang, W.; Biju, P.G.; Krager, K.J.; et al. Characterization of transgenic Gfrp knock-in mice: Implications for tetrahydrobiopterin in modulation of normal tissue radiation responses. Antioxid. Redox Signal. 2014, 20, 1436–1446. [Google Scholar] [CrossRef] [PubMed]
  36. Berbee, M.; Fu, Q.; Boerma, M.; Pathak, R.; Zhou, D.; Kumar, K.S.; Hauer-Jensen, M. Reduction of radiation-induced vascular nitrosative stress by the vitamin E analog γ-tocotrienol: Evidence of a role for tetrahydrobiopterin. Int. J. Radiat. Oncol. Biol. Phys. 2011, 79, 884–891. [Google Scholar] [CrossRef] [PubMed]
  37. Kohnen, S.L.; Mouithys-Mickalad, A.A.; Deby-Dupont, G.P.; Deby, C.M.; Lamy, M.L.; Noels, A.F. Oxidation of tetrahydrobiopterin by peroxynitrite or oxoferryl species occurs by a radical pathway. Free Radic. Res. 2001, 35, 709–721. [Google Scholar] [CrossRef] [PubMed]
  38. Kuzkaya, N.; Weissmann, N.; Harrison, D.G.; Dikalov, S. Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: Implications for uncoupling endothelial nitric-oxide synthase. J. Biol. Chem. 2003, 278, 22546–22554. [Google Scholar] [CrossRef] [PubMed]
  39. Chen, X.L.; Li, W.B.; Zhou, A.M.; Ai, J.; Huang, S.S. Role of endogenous peroxynitrite in pulmonary injury and fibrosis induced by bleomycin A5 in rats. Acta Pharmacol. Sin. 2003, 24, 697–702. [Google Scholar] [PubMed]
  40. Hanaue, N.; Takeda, I.; Kizu, Y.; Tonogi, M.; Yamane, G.Y. Peroxynitrite formation in radiation-induced salivary gland dysfunction in mice. Biomed. Res. 2007, 28, 147–151. [Google Scholar] [CrossRef] [PubMed]
  41. Al-Nimer, M.S.; Ali, N.H. Assessment of nitrosative stress and lipid peroxidation activity in asymptomatic exposures to medical radiation: The bystander effect of ionizing radiation. Int. J. Appl. Basic Med. Res. 2012, 2, 48–51. [Google Scholar] [CrossRef] [PubMed]
  42. Gao, L.; Chalupsky, K.; Stefani, E.; Cai, H. Mechanistic insights into folic acid-dependent vascular protection: Dihydrofolate reductase (DHFR)-mediated reduction in oxidant stress in endothelial cells and angiotensin ii-infused mice: A novel hplc-based fluorescent assay for dhfr activity. J. Mol. Cell Cardiol. 2009, 47, 752–760. [Google Scholar] [CrossRef] [PubMed]
  43. Mitchell, B.M.; Dorrance, A.M.; Webb, R.C. Phenylalanine improves dilation and blood pressure in GTP cyclohydrolase inhibition-induced hypertensive rats. J. Cardiovasc. Pharmacol. 2004, 43, 758–763. [Google Scholar] [CrossRef] [PubMed]
  44. Mitchell, B.M.; Dorrance, A.M.; Mack, E.A.; Webb, R.C. Glucocorticoids decrease GTP cyclohydrolase and tetrahydrobiopterin-dependent vasorelaxation through glucocorticoid receptors. J. Cardiovasc. Pharmacol. 2004, 43, 8–13. [Google Scholar] [CrossRef] [PubMed]
  45. Nandi, M.; Kelly, P.; Vallance, P.; Leiper, J. Over-expression of GTP-cyclohydrolase 1 feedback regulatory protein attenuates LPS and cytokine-stimulated nitric oxide production. Vasc. Med. 2008, 13, 29–36. [Google Scholar] [CrossRef] [PubMed]
  46. Zhao, Y.; Zhu, H.; Zou, M.H. Non-covalent interaction between polyubiquitin and GTP cyclohydrolase 1 dictates its degradation. PLoS One 2012, 7, e43306. [Google Scholar] [CrossRef] [PubMed]
  47. Zhao, Y.; Wu, J.; Zhu, H.; Song, P.; Zou, M.H. Peroxynitrite-dependent zinc release and inactivation of guanosine 5′-triphosphate cyclohydrolase 1 instigate its ubiquitination in diabetes. Diabetes 2013, 62, 4247–4256. [Google Scholar] [CrossRef] [PubMed]
  48. Li, L.; Rezvan, A.; Salerno, J.C.; Husain, A.; Kwon, K.; Jo, H.; Harrison, D.G.; Chen, W. GTP cyclohydrolase I phosphorylation and interaction with GTP cyclohydrolase feedback regulatory protein provide novel regulation of endothelial tetrahydrobiopterin and nitric oxide. Circ. Res. 2010, 106, 328–336. [Google Scholar] [CrossRef] [PubMed]
  49. Kalivendi, S.; Hatakeyama, K.; Whitsett, J.; Konorev, E.; Kalyanaraman, B.; Vasquez-Vivar, J. Changes in tetrahydrobiopterin levels in endothelial cells and adult cardiomyocytes induced by LPS and hydrogen peroxide—A role for GFRP? Free Radic. Biol. Med. 2005, 38, 481–491. [Google Scholar] [CrossRef] [PubMed]
  50. Werner, E.R.; Bahrami, S.; Heller, R.; Werner-Felmayer, G. Bacterial lipopolysaccharide down-regulates expression of GTP cyclohydrolase I feedback regulatory protein. J. Biol. Chem. 2002, 277, 10129–10133. [Google Scholar] [CrossRef] [PubMed]
  51. Cheema, A.K.; Pathak, R.; Zandkarimi, F.; Kaur, P.; Alkhalil, L.; Singh, R.; Zhong, X.; Ghosh, S.; Aykin-Burns, N.; Hauer-Jensen, M. Liver metabolomics reveals increased oxidative stress and fibrogenic potential in GFRP transgenic mice in response to ionizing radiation. J. Proteome Res. 2014, 13, 3065–3074. [Google Scholar] [CrossRef] [PubMed]
  52. Tatham, A.L.; Crabtree, M.J.; Warrick, N.; Cai, S.; Alp, N.J.; Channon, K.M. GTP cyclohydrolase I expression, protein, and activity determine intracellular tetrahydrobiopterin levels, independent of gtp cyclohydrolase feedback regulatory protein expression. J. Biol. Chem. 2009, 284, 13660–13668. [Google Scholar] [CrossRef] [PubMed]
  53. Shiraishi, H.; Ikemoto, K.; Tada, S.; Udagawa, Y.; Ohtsuki, M.; Sumi-Ichinose, C.; Kondo, K.; Nomura, T. Cilostazol inhibits cytokine-induced tetrahydrobiopterin biosynthesis in human umbilical vein endothelial cells. J. Atheroscler. Thromb. 2011, 18, 312–317. [Google Scholar] [CrossRef] [PubMed]
  54. Magne, N.; Toillon, R.A.; Bottero, V.; Didelot, C.; Houtte, P.V.; Gerard, J.P.; Peyron, J.F. NF-κB modulation and ionizing radiation: Mechanisms and future directions for cancer treatment. Cancer Lett. 2006, 231, 158–168. [Google Scholar] [CrossRef] [PubMed]
  55. Nagane, M.; Yasui, H.; Sakai, Y.; Yamamori, T.; Niwa, K.; Hattori, Y.; Kondo, T.; Inanami, O. Activation of eNOS in endothelial cells exposed to ionizing radiation involves components of the DNA damage response pathway. Biochem. Biophys. Res. Commun. 2015, 456, 541–546. [Google Scholar] [CrossRef] [PubMed]
  56. Ohta, S.; Matsuda, S.; Gunji, M.; Kamogawa, A. The role of nitric oxide in radiation damage. Biol. Pharm. Bull. 2007, 30, 1102–1107. [Google Scholar] [CrossRef] [PubMed]
  57. Kim, R.K.; Suh, Y.; Cui, Y.H.; Hwang, E.; Lim, E.J.; Yoo, K.C.; Lee, G.H.; Yi, J.M.; Kang, S.G.; Lee, S.J. Fractionated radiation-induced nitric oxide promotes expansion of glioma stem-like cells. Cancer Sci. 2013, 104, 1172–1177. [Google Scholar] [CrossRef] [PubMed]
  58. Ibuki, Y.; Mizuno, S.; Goto, R. Gamma-irradiation-induced DNA damage enhances no production via NF-κB activation in raw264.7 cells. Biochim. Biophys. Acta 2003, 1593, 159–167. [Google Scholar] [CrossRef] [PubMed]
  59. Landmesser, U.; Dikalov, S.; Price, S.R.; McCann, L.; Fukai, T.; Holland, S.M.; Mitch, W.E.; Harrison, D.G. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J. Clin. Investig. 2003, 111, 1201–1209. [Google Scholar] [CrossRef] [PubMed]
  60. Huang, A.; Zhang, Y.Y.; Chen, K.; Hatakeyama, K.; Keaney, J.F., Jr. Cytokine-stimulated GTP cyclohydrolase I expression in endothelial cells requires coordinated activation of nuclear factor-κB and Stat1/Stat3. Circ. Res. 2005, 96, 164–171. [Google Scholar] [CrossRef] [PubMed]
  61. Schneider, L.; Pellegatta, S.; Favaro, R.; Pisati, F.; Roncaglia, P.; Testa, G.; Nicolis, S.K.; Finocchiaro, G.; D’Adda di Fagagna, F. DNA damage in mammalian neural stem cells leads to astrocytic differentiation mediated by BMP2 signaling through JAK-STAT. Stem Cell Rep. 2013, 1, 123–138. [Google Scholar] [CrossRef]
  62. Dawson, L.A.; Ten Haken, R.K.; Lawrence, T.S. Partial irradiation of the liver. Semin. Radiat. Oncol. 2001, 11, 240–246. [Google Scholar] [CrossRef] [PubMed]
  63. Lin, R.X.; Zhao, H.B.; Li, C.R.; Sun, Y.N.; Qian, X.H.; Wang, S.Q. Proteomic analysis of ionizing radiation-induced proteins at the subcellular level. J. Proteome Res. 2009, 8, 390–399. [Google Scholar] [CrossRef] [PubMed]
  64. Dawson, L.A.; Normolle, D.; Balter, J.M.; McGinn, C.J.; Lawrence, T.S.; Ten Haken, R.K. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int. J. Radiat. Oncol. Biol. Phys. 2002, 53, 810–821. [Google Scholar] [CrossRef] [PubMed]
  65. Cheng, J.C.; Wu, J.K.; Huang, C.M.; Liu, H.S.; Huang, D.Y.; Cheng, S.H.; Tsai, S.Y.; Jian, J.J.; Lin, Y.M.; Cheng, T.I.; et al. Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: Dosimetric analysis and implication. Int. J. Radiat. Oncol. Biol. Phys. 2002, 54, 156–162. [Google Scholar] [CrossRef] [PubMed]
  66. Anscher, M.S.; Crocker, I.R.; Jirtle, R.L. Transforming growth factor-β1 expression in irradiated liver. Radiat. Res. 1990, 122, 77–85. [Google Scholar] [CrossRef] [PubMed]
  67. Flechsig, P.; Dadrich, M.; Bickelhaupt, S.; Jenne, J.; Hauser, K.; Timke, C.; Peschke, P.; Hahn, E.W.; Grone, H.J.; Yingling, J.; et al. Ly2109761 attenuates radiation-induced pulmonary murine fibrosis via reversal of TGF-β and BMP-associated proinflammatory and proangiogenic signals. Clin. Cancer Res. 2012, 18, 3616–3627. [Google Scholar] [CrossRef] [PubMed]
  68. Boothe, D.L.; Coplowitz, S.; Greenwood, E.; Barney, C.L.; Christos, P.J.; Parashar, B.; Nori, D.; Chao, K.S.; Wernicke, A.G. Transforming growth factor β-1 (TGF-β1) is a serum biomarker of radiation induced fibrosis in patients treated with intracavitary accelerated partial breast irradiation: Preliminary results of a prospective study. Int. J. Radiat. Oncol. Biol. Phys. 2013, 87, 1030–1036. [Google Scholar] [CrossRef] [PubMed]
  69. De Winter-de Groot, K.M.; van Haren Noman, S.; Speleman, L.; Schilder, A.G.; van der Ent, C.K. Nasal nitric oxide levels and nasal polyposis in children and adolescents with cystic fibrosis. JAMA Otolaryngol. Head Neck Surg. 2013, 139, 931–936. [Google Scholar] [CrossRef] [PubMed]
  70. Michl, R.K.; Hentschel, J.; Fischer, C.; Beck, J.F.; Mainz, J.G. Reduced nasal nitric oxide production in cystic fibrosis patients with elevated systemic inflammation markers. PLoS One 2013, 8, e79141. [Google Scholar] [CrossRef] [PubMed]
  71. Moens, A.L.; Takimoto, E.; Tocchetti, C.G.; Chakir, K.; Bedja, D.; Cormaci, G.; Ketner, E.A.; Majmudar, M.; Gabrielson, K.; Halushka, M.K.; et al. Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: Efficacy of recoupling nitric oxide synthase as a therapeutic strategy. Circulation 2008, 117, 2626–2636. [Google Scholar] [CrossRef] [PubMed]
  72. Vasquez-Vivar, J.; Martasek, P.; Whitsett, J.; Joseph, J.; Kalyanaraman, B. The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: An epr spin trapping study. Biochem. J. 2002, 362, 733–739. [Google Scholar] [CrossRef] [PubMed]
  73. Heller, R.; Unbehaun, A.; Schellenberg, B.; Mayer, B.; Werner-Felmayer, G.; Werner, E.R. l-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J. Biol. Chem. 2001, 276, 40–47. [Google Scholar] [CrossRef] [PubMed]
  74. Hattori, Y.; Nakanishi, N.; Akimoto, K.; Yoshida, M.; Kasai, K. HMG-CoA reductase inhibitor increases GTP cyclohydrolase I mrna and tetrahydrobiopterin in vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2003, 23, 176–182. [Google Scholar] [CrossRef] [PubMed]
  75. Hu, Z.P.; Kim, Y.M.; Sowa, M.B.; Robinson, R.J.; Gao, X.; Metz, T.O.; Morgan, W.F.; Zhang, Q. Metabolomic response of human skin tissue to low dose ionizing radiation. Mol. Biosyst. 2012, 8, 1979–1986. [Google Scholar] [CrossRef] [PubMed]
  76. Liu, H.; Wang, Z.; Zhang, X.; Qiao, Y.; Wu, S.; Dong, F.; Chen, Y. Selection of candidate radiation biomarkers in the serum of rats exposed to γ-rays by GC/TOFMS-based metabolomics. Radiat. Prot. Dosim. 2013, 154, 9–17. [Google Scholar] [CrossRef]
  77. Johnson, C.H.; Patterson, A.D.; Krausz, K.W.; Kalinich, J.F.; Tyburski, J.B.; Kang, D.W.; Luecke, H.; Gonzalez, F.J.; Blakely, W.F.; Idle, J.R. Radiation metabolomics. 5. Identification of urinary biomarkers of ionizing radiation exposure in nonhuman primates by mass spectrometry-based metabolomics. Radiat. Res. 2012, 178, 328–340. [Google Scholar] [CrossRef] [PubMed]
  78. Khan, A.R.; Rana, P.; Devi, M.M.; Chaturvedi, S.; Javed, S.; Tripathi, R.P.; Khushu, S. Nuclear magnetic resonance spectroscopy-based metabonomic investigation of biochemical effects in serum of γ-irradiated mice. Int. J. Radiat. Biol. 2011, 87, 91–97. [Google Scholar] [CrossRef] [PubMed]
  79. Johnson, C.H.; Patterson, A.D.; Krausz, K.W.; Lanz, C.; Kang, D.W.; Luecke, H.; Gonzalez, F.J.; Idle, J.R. Radiation metabolomics. 4. UPLC-ESI-QTOFMS-Based metabolomics for urinary biomarker discovery in γ-irradiated rats. Radiat. Res. 2011, 175, 473–484. [Google Scholar] [CrossRef] [PubMed]
  80. Lanz, C.; Patterson, A.D.; Slavik, J.; Krausz, K.W.; Ledermann, M.; Gonzalez, F.J.; Idle, J.R. Radiation metabolomics. 3. Biomarker discovery in the urine of γ-irradiated rats using a simplified metabolomics protocol of gas chromatography-mass spectrometry combined with random forests machine learning algorithm. Radiat. Res. 2009, 172, 198–212. [Google Scholar] [CrossRef] [PubMed]
  81. Tyburski, J.B.; Patterson, A.D.; Krausz, K.W.; Slavik, J.; Fornace, A.J., Jr.; Gonzalez, F.J.; Idle, J.R. Radiation metabolomics. 2. Dose- and time-dependent urinary excretion of deaminated purines and pyrimidines after sublethal γ-radiation exposure in mice. Radiat. Res. 2009, 172, 42–57. [Google Scholar] [CrossRef] [PubMed]
Antioxidants EISSN 2076-3921 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top